Manuel Corpas

CEO/Founder Cambridge Precision Medicine.

Graduated in Biomedical Sciences at the University of Navarra, Manuel Corpas focused in the human genome since the very beginning of his career. He has worked in the National Institute of Bioinformatics and the Sanger Institute of genome analysis. Besides, he has lead a research about animal and plant’s genome in The Genome Analysis Center. Last 2016 he joined Repositive, a start-up specialized in sharing and storing genomes of different types. The aim is expanding and disseminating the expertise of this field of science. Now he is the CEO/Founder of Cambridge Precision Medicine.